If you’re considering treatment for hepatitis C, your doctor may recommend Epclusa. It’s a prescription drug that’s used in adults and some children to treat hepatitis C, which is caused by hepatitis ...

Hepatitis C is one of the most common viral infections in the United States. Without treatment, hepatitis C can lead to severe health issues. Epclusa was approved to treat chronic hepatitis C by the ...

The National Institute for Health and Care Excellence has now published final guidance endorsing Epclusa as an option for the treatment of adults with chronic hepatitis C genotype 1-6 infection on the ...

Federal health officials on Tuesday approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus ...

Epclusa (sofosbuvir/velpatasvir) is a brand-name prescription medication. It’s approved by the Food and Drug Administration (FDA) to treat hepatitis C, which is an ...

The U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). For patients with moderate ...

The National Institute for Health and Care Excellence is endorsing Gilead's pan-genotypic hepatitis C drug Epclusa for routine NHS use in England and Wales. The National Institute for Health and Care ...

NICE has recommended Gilead’s Epclusa as a treatment option for all genotypes of hepatitis C in first draft guidance. Trial data has shown recently-approved Epclusa (sofosbuvir+velpatasvir) gives cure ...

HealthDay News — The combination drug Epclusa has been approved by the US Food and Drug Administration to treat the 6 major strains of chronic hepatitis C virus. Epclusa combines sofosbuvir, ...

Gilead Sciences isn't letting a few of its own generics interfere with advertising its pan-genotypic hep C drug Epclusa. The Big Biotech is turning to TV again to promote its hep C franchise, this ...

TALLAHASSEE, Fla. (WCTV) -- Here's a question: how much would you pay for a life-changing prescription? The FDA is approving a brand new drug to cure Hepatitis C. Hep-C is a virus that attacks the ...

Sofosbuvir, velpatasvir; 150mg/37.5mg, 200mg/50mg; per packet. Sofosbuvir is an inhibitor of the HCV NS5B RNA-dependent RNA polymerase, which is required for viral replication. Sofosbuvir is a ...